Orphan designation: Relacorilant Treatment of pancreatic cancer, 21/08/2019 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 22 October 2024 - 14:34

Orphan designation: Relacorilant Treatment of pancreatic cancer, 21/08/2019 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-19-2191

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters